Quality of antiretroviral and opportunistic infection medications dispensed from developing countries and Internet pharmacies

Journal of Clinical Pharmacy and Therapeutics

Volumn 40, Issue 1, 2015, Pages 68-75

  Wang, Ting ^a   Hoag, Stephen W ^a   Eng, Maria L ^b   Polli, James ^a   Pandit, Neha Sheth ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b Center for Interpreting Health Benefits and Risks   (United States)

Author keywords

antibiotic prophylaxis; medication; quality

Indexed keywords

ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; EFAVIRENZ; ISONIAZID; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE; GENERIC DRUG;

ARTICLE; CHINA; DEVELOPING COUNTRY; DRUG CAPSULE; DRUG FORMULARY; DRUG QUALITY; DRUG SOLUBILITY; ETHIOPIA; HEALTH CARE ACCESS; INTERNET; LAOS; MEXICO; NIGERIA; OPPORTUNISTIC INFECTION; PHARMACY; SOUTH AFRICA; TABLET; THAILAND; UNITED STATES; HEALTH CARE QUALITY; HUMAN; OPPORTUNISTIC INFECTIONS; STANDARDS;

ANTI-INFECTIVE AGENTS; ANTI-RETROVIRAL AGENTS; CHINA; DEVELOPING COUNTRIES; DRUGS, GENERIC; ETHIOPIA; HUMANS; INTERNET; LAOS; MEXICO; NIGERIA; OPPORTUNISTIC INFECTIONS; PHARMACEUTICAL SERVICES, ONLINE; PHARMACIES; QUALITY OF HEALTH CARE; SOUTH AFRICA; THAILAND; UNITED STATES;

EID: 84920268058     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12226     Document Type: Article

References (22)

1. Wainberg MA,. Generic HIV drugs-enlightened policy for global health. N Engl J Med, 2005; 352: 747-750.
2. Progress on Global Access to HIV Antiretroviral Therapy: An update on "3 by 5". UNAIDS and World Health Organization, Updated June 2005.
3. Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector. World Health Organization, Updated: Progress Report 2011.
4. Steinbrook R,. Closing the affordability gap for drugs in low-income countries. N Engl J Med, 2007; 357: 1996-1999.
5. Media Reports on Medicine Quality: Focusing on USAID-assisted countries. U.S. Pharmacopeia Drug Quality and information program, Updated: August, 2012.
6. Sidley P,. South Africa withdraws TB drugs because of quality fears. Br Med J, 2008; 337: a1385.
7. HSI seizes 686 websites selling counterfeit medicine to unsuspecting consumers. U.S. Immigration and Customs Enforcement [Internet], 2012 Oct 4. Available at: http://www.ice.gov/news/releases/1210/121004washingtondc.htm
8. General information on counterfeit medicines. The World Health Organization [Internet]. Available at: http://www.who.int/medicines/services/counterfeit/overview/en/
9. Penzak SR, Acosta EP, Turner M, Tavel JA, Masur H,. Antiretroviral drug content in products from developing countries. Clin Infect Dis, 2004; 38: 1317-1319.
10. Penzak SR, Acosta EP, Turner M, Tavel JA, Masur H,. Analysis of generic nevirapine products in developing countries. J Am Med Assoc, 2003; 289: 2648-2649.
11. Ramachandran G, Perloff ES, von Moltke LL, Swaminathan S, Wanke CA, Greenblatt DJ,. Analysis of generic antiretroviral formulations manufactured in India. AIDS, 2004; 18: 1482-1484.
12. Laurent C, Kouanfack C, Koulla-Shiro S, et al,. Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine. AIDS, 2007; 21: 768-771.
13. Taylor RB, Shakoor O, Behrens RH, et al,. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet, 2001; 357: 1933-1936.
14. Find a VIPPS online pharmacy; National Association of Boards of Pharmacy [Internet], Available at: http://www.nabp.net/programs/accreditation/vipps/find-a-vipps-online-pharmacy/
15. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services [Internet], 2013; Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf.
16. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. World Health Organizations [Internet], 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241599764-eng.pdf
17. Aberg JA, Kaplan JE, Libman H, et al,. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis, 2009; 49: 651-681.
18. The Official Compendia of Standards. USP 32-NF 27. Rockville, MD: United States Pharmacopeia Convention, Inc., 2005.
19. Hoag SW, Ramachandruni H, Shangraw R,. Failure of prescription prenatal vitamin products to meet USP standards for folic acid dissolution. J Am Pharm Assoc (Wash), 1997; NS37: 397-400.
20. Risha PG, Shewiyo D, Msami A, Masuki G, Vergote G, Vervaet C, Remon JP,. In vitro evaluation of the quality of essential drugs on the Tanzanian market. Tropical Med Int Health, 2002; 7: 701-707.
21. Fernandes C, Junqueira RG, Campos LM, Pianetti GA,. Dissolution test for lamivudine tablets: optimization and statistical analysis. J Pharm Biomed Anal, 2006; 42: 601-606.
22. Troy DB,. Remington: The science and practice of pharmacy, 21st edn. Baltimore, MD: Lippincott Williams & Wilkins, 916, 2005.